Mdma

A new study on MDMA, or "Ecstasy," and PTSD patients shows the potency of powerful new treatments based on psychedelic drugs.

A private non-profit research group seeking to conduct a final phase of clinical trials of MDMA, the main ingredient in the recreational drug ecstasy, got a major boost from Silicon Valley and Wall Street donors.

"Wastewater analysis has demonstrated its utility over the last decade as an important new drug monitoring tool," said Alexis Goosdeel from the European Union's drugs agency.

Newsweek spoke to the co-author of Love Drugs: The Chemical Future of Relationships about the ethics of intervening in this fundamental part of being human with psychoactive substances.

The study involved almost 800 people who were going to parties in New York City.

There has been an influx of ecstasy into Australia and New Zealand.

The findings come amid what is known as the "psychedelic renaissance."

The research comes amid a "psychedelic renaissance," in which scientists have investigated whether psychoactive drugs such as MDMA and LSD could be used to treat mental illnesses such as depression, anxiety and PTSD.

MDMA is known to produce pro-social effects in humans.

Recently, researchers have been looking at how the pure form of MDMA can be used in therapy to treat mental health problems.

MDMA has been illegal in the U.S. since 1985, but clinical trials have showed that the drug enhances the treatment of PTSD.

More than a dozen arrests were made before the "Holy Ship!" party cruise embarked from Port Canaveral.

MDMA is a psychoactive compound, commonly known as ecstasy, that's primarily used as a recreational drug.

MDMA-assisted psychotherapy has previously shown promise in the treatment of a variety of conditions ranging from post-traumatic stress disorder to depression and alcohol addiction.

Findings suggest that psychedelics could be used to treat a host of mood and anxiety disorders, such as depression, anxiety, addiction and post-traumatic stress disorder.

The drug has also been eyed to treat depression and PTSD.

Spain beats Swiss cities in the cocaine top 10; amphetamine is big in Germany and the Low Countries; and Amsterdam is a runaway leader for MDMA use.

This comes after the Food and Drug Administration designated MDMA as a "breakthrough therapy."

Study also found that purity testing at music festivals can curb use of adulterated drugs.

Only 0.2 percent of people who tried shrooms within the last year wound up in the emergency room, according to the Global Drug Survey.

The warning comes after three 12-year-olds in the U.K. swallowed pills with soft drinks.

Zachary Kramer was arrested after about a dozen classmates were hospitalized after taking what they thought was MDMA.

One person also tested positive for a dangerous substance called flakka.

Psilocybin, LSD and other chemicals should be extensively studied, scientists say.

The number of deaths and poison center calls about synthetic cannabinoids have skyrocketed since 2014.

A letter published in the Lancet Psychiatry Journal has claimed that psychedelic drugs are safer than currently thought.

Law enforcement and advocacy groups say "molly" has become nothing more than a marketing term.

Police have arrested four people who they suspect provided the club drug known as Molly to people at Wesleyan University, resulting in hospitalizations on February 22.

Police are investigating why the MDMA caused symptoms consistent with overdoses.